Jungsil Ro
Western University(CA)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Breast Lesions and Carcinomas
Most-Cited Works
- → Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer(2015)2,084 cited
- → Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial(2016)1,795 cited
- → Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer(2015)1,569 cited
- → Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer(2018)1,261 cited
- → De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017(2017)1,245 cited
- → Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study(2013)992 cited
- → Nucleoprotein complexes that regulate gene expression in adipocyte differentiation: direct participation of c-fos(1987)524 cited
- → Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer(2007)518 cited
- → Adipocyte P2 gene: developmental expression and homology of 5'-flanking sequences among fat cell-specific genes.(1986)334 cited
- → Micropapillary Component in Lung Adenocarcinoma(2002)330 cited